This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,280.00 firm-fixed-price delivery order is for the supply of 120 tablets of Abiraterone Acetate 250 mg, a medication used in the treatment of prostate cancer.
The contract has an ultimate completion date of November 7, 2024 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award is likely a task order issued against that larger IDC contract.
Generated 2/5/25, 9:31 AM